课题基金 / 基金详情

项目摘要

项目成果

Kenneth R MCLEISH的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):系统性红斑狼疮(SLE)的肾脏受累,称为狼疮性肾炎(LN),约60%的患者发生,是发病率和死亡率的主要原因。膜性狼疮性肾炎(MLN)(V类)在这些患者的肾活检中占15%至40%。所有类型LN的拟议发病机制是含有自身抗体的免疫复合物在肾小球沉积。已经提出了描述含有致肾抗体的免疫复合物如何沉积在肾小球中的三种假说,即循环免疫复合物的沉积、抗核抗体与“种植”在肾小球中的抗原的结合以及抗核抗体与肾小球成分的交叉反应性。一种蛋白质组学方法,类似于本申请中提出的方法,用于确定M型磷脂酶A2受体(PLA2R)的自身抗体是特发性膜性肾病中免疫复合物沉积的原因。这种抗体存在于70%至80%的特发性膜性肾病患者中,但不存在于MLN患者中。这提出了一个新的假设,即MLN患者产生了针对肾小球毛细血管内源性成分的独特自身抗体。目前的建议将使用蛋白质组学的方法,成功地采用了我们的小组在特发性膜性肾病,以确定和验证特定的肾小球蛋白,导致MLN的自身抗体是针对。
英文摘要
DESCRIPTION (provided by applicant): Renal involvement in systemic lupus erythematosus (SLE), termed lupus nephritis (LN), occurs in about 60% of patients and is a leading cause of morbidity and mortality. Membranous lupus nephritis (MLN) (class V) is described in 15% to 40% of renal biopsies in these patients. The proposed pathogenesis of all classes LN is the glomerular deposition of immune complexes containing auto-antibodies. Three hypotheses describing how immune complexes containing nephritigenic antibodies are deposited in glomeruli have been proposed, deposition of circulating immune complexes, binding of anti-nuclear antibodies to antigens "planted" in the glomerulus, and cross reactivity of anti-nuclear antibodies with glomerular constituents. A proteomic approach, similar to that proposed in this application, was used to determine that an auto-antibody to the M-type phospholipase A2 receptor (PLA2R) is responsible for immune complex deposition in idiopathic membranous nephropathy. This antibody is present in 70% to 80% of patients with idiopathic membranous nephropathy, but it is not present in patients with MLN. This suggests a new hypothesis that patients with MLN develop unique auto-antibodies against an endogenous component of the glomerular capillary. The current proposal will use proteomic approaches that were successfully employed by our group in idiopathic membranous nephropathy to identify and verify specific glomerular proteins to which autoantibodies that cause MLN are directed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a Neutrophil Degranulation Inhibitor to Treat ARDS
  • 批准号:
    10697442
  • 项目类别:
  • 资助金额:
    $30.64万
  • 财政年份:
    2023
  • 负责人:
    Kenneth R MCLEISH
  • 依托单位:
Identification of diagnostic markers for lupus nephritis
  • 批准号:
    8606402
  • 项目类别:
  • 资助金额:
    $18.67万
  • 财政年份:
    2013
  • 负责人:
    Kenneth R MCLEISH
  • 依托单位:
Mechanism of Neutrophil Activation
Mechanism of Neutrophil Activation
海外基金